ESC 365 - Lipid lowering in kidney disease. What to do? What to avoid?

Open Access

Lipid lowering in kidney disease. What to do? What to avoid?

Session: Improving secondary prevention of atherosclerotic disease

Topic: Epidemiology, lipids

Speaker: Professor S. Nicholls (Melbourne, AU)

Event: ESC CONGRESS 2016

Congress Session

About the speaker

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)

36 presentations

1 follower

3 more presentations in this session

Usually statins and ezetimibe are enough

Speaker: Professor P. Steg (Paris, FR)

New concept with PCSK9 inhibitors

Speaker: Professor G. Dan (Bucharest, RO)

Lipids lowering in diabetics. What is the best way?

Speaker: Professor F. Van de Werf (Leuven, BE)

Access the full session

Improving secondary prevention of atherosclerotic disease

Speakers: Professor S. Nicholls, Professor P. Steg, Professor G. Dan, Professor F. Van de Werf

About the event

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Congress

This platform is supported by